We’re proud to announce that MedAware, an OurCrowd portfolio company, has closed its investment of $1 million from GE Ventures and OurCrowd investors. This financing round marks the first investment the venture capital arm of GE, GE Ventures, has made as part of the strategic co-investment partnership OurCrowd signed with the firm back in November 2013.
We believe we have reached a real milestone and transformative moment in the world of high-tech finance. This investment underscores the fact that the startup investment playing field is being levelled — OurCrowd investors get access to the same deals multi-billion dollar corporations are seeing, at the same terms.
We are looking forward to driving innovation forward with GE Ventures, whose unequalled expertise and experience in a broad range of technologies and businesses add real value to our portfolio companies and to our investor community.
“We are excited about the potential for MedAware to solve the huge problem of prescription error via their impressive big data technology,” said Jon Medved, founder and CEO of OurCrowd. “The fact that our partner, General Electric, has joined together with us in this investment is further validation of this tremendous opportunity.”
Read the full press release here.